Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical, biological and histological characteristics of bullous pemphigoid associated with anti-PD-1/PD-L1 therapy: A national retrospective study.
Juzot C, Sibaud V, Amatore F, Mansard S, Seta V, Jeudy G, Pham-Ledard A, Benzaquen M, Peuvrel L, Le Corre Y, Lesage C, Viguier M, Baroudjian B, Dréno B, Quéreux G. Juzot C, et al. Among authors: seta v. J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e511-e514. doi: 10.1111/jdv.17253. Epub 2021 Apr 13. J Eur Acad Dermatol Venereol. 2021. PMID: 33783881 No abstract available.
Transient abdominal telangiectasia of the newborn.
Juzot C, Aubert H, Bessis D, Boccara O, Bourrat E, Chiaverini C, Flamant C, Fournet M, Hubiche T, Labrèze C, Martin L, Piram M, Seta V, Finon A, Maruani A, Barbarot S; “Groupe de Recherche Clinique de Dermatologie Pédiatrique”. Juzot C, et al. Among authors: seta v. Pediatr Dermatol. 2021 Jul;38(4):864-867. doi: 10.1111/pde.14620. Epub 2021 Jun 21. Pediatr Dermatol. 2021. PMID: 34152036
Real-life impact of immunologic tests to predict relapse after treatment cessation in patients with bullous pemphigoid: A French multicenter retrospective study.
Battesti G, Garcia C, Viguier M, Marchal V, Castel M, Joly P, Ledard AP, Konstantinou MP, Seta V, Cordel N, Duvert-Lehembre S, Tancrède-Bohin E, Belmondo T, Ingen-Housz-Oro S, d'Incan M. Battesti G, et al. Among authors: seta v. J Am Acad Dermatol. 2022 Jun;86(6):1293-1300. doi: 10.1016/j.jaad.2022.01.016. Epub 2022 Jan 26. J Am Acad Dermatol. 2022. PMID: 35091001
Anti-BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis.
Cordel N, Flament J, Jouen F, Seta V, Tancrède-Bohin E, Dahan CP, Konstantinou MP, Dereure O, Quéreux G, Prost C, Bedane C, Debarbieux S, Lacour JP, Dompmartin A, Wierzbicka-Hainaut E, Villada IB, Oro SIH, Vabres P, Richard MA, Delaporte E, Pham-Ledard A, Leccia MT, Litrowski N, Michel C, Lagrange B, D'Incan M, Abasq C, Duvert-Lehembre S, Dupuy A, Alcaraz I, Breton-Guitarian AL, Lombart F, Estève E, Machet L, Del Giudice P, Fenot M, Belmondo T, Morin F, Guérin O, Benichou J, Tressières B, Joly P; French study Group on autoimmune bullous skin diseases. Cordel N, et al. Among authors: seta v. J Eur Acad Dermatol Venereol. 2023 Jun;37(6):1207-1214. doi: 10.1111/jdv.18973. Epub 2023 Mar 6. J Eur Acad Dermatol Venereol. 2023. PMID: 36802102
Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients.
Chebani R, Lombart F, Chaby G, Dadban A, Debarbieux S, Viguier MA, Ingen-Housz-Oro S, Pham-Ledard A, Bedane CR, Picard-Dahan C, Berthin C, Dereure O, Konstantinou MP, Castel M, Jouen F, Joly P, Seta V, Duvert-Lehembre S, Le Roux C, Quereux G, Sassolas B, Brenaut E, Sin C, Richard MA, Bérard F, Giusti D, Belmondo T, Gille T, Caux F, Prost-Squarcioni C, Grootenboer-Mignot S, Alexandre M; French Study Group on Autoimmune Bullous Diseases. Chebani R, et al. Among authors: seta v. Br J Dermatol. 2024 Jan 23;190(2):258-265. doi: 10.1093/bjd/ljad369. Br J Dermatol. 2024. PMID: 37792727
Bullous pemphigoid: Three main clusters defining 3 outcome profiles.
Guerrois F, Hassan E, Bettuzzi T, Seta V, Goulvestre C, Jelti L, Belmondo T, Wolkenstein P, Aractingi S, Ingen-Housz-Oro S, Dupin N. Guerrois F, et al. Among authors: seta v. J Am Acad Dermatol. 2022 Aug;87(2):359-365. doi: 10.1016/j.jaad.2022.04.029. Epub 2022 Apr 26. J Am Acad Dermatol. 2022. PMID: 35483492
SARS-CoV-2 vaccination may trigger and exacerbate mucosal lichen planus.
Dangien A, Darbord D, Chanal J, Wendling J, Pantoja C, Oules B, Lheure C, Ouedraogo E, Kramkimel N, Barret M, Beuvon F, Plantier F, Guegan S, Aractingi S, Seta V, Sohier P, Isnard C, Dupin N. Dangien A, et al. Among authors: seta v. J Eur Acad Dermatol Venereol. 2023 Sep;37(9):e1094-e1096. doi: 10.1111/jdv.19144. Epub 2023 May 6. J Eur Acad Dermatol Venereol. 2023. PMID: 37114298 No abstract available.
Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients.
Gaudin O, Seta V, Alexandre M, Bohelay G, Aucouturier F, Mignot-Grootenboer S, Ingen-Housz-Oro S, Bernardeschi C, Schneider P, Mellottee B, Caux F, Prost-Squarcioni C. Gaudin O, et al. Among authors: seta v. Front Immunol. 2018 May 24;9:1030. doi: 10.3389/fimmu.2018.01030. eCollection 2018. Front Immunol. 2018. PMID: 29881377 Free PMC article.
32 results